Intervention in diabetic vascular disease by modulation of growth factors

Area of Science:

• Endocrinology and Metabolism
• Vascular Biology
• Pharmacology

Background:

• Diabetes mellitus is associated with cellular metabolism and proliferation derangements.
• These derangements contribute to diabetic microvascular and macrovascular complications, including kidney mesangial expansion, retinal neovascularization, and atherosclerosis.
• Growth factors play a significant role in these pathological processes.

Purpose of the Study:

• To review the role of growth factors in diabetic vasculopathy.
• To discuss current and potential pharmacological interventions for managing diabetic vascular disease.

Main Methods:

• Literature review of studies investigating growth factors in diabetes.
• Analysis of pharmacological interventions targeting growth factor alterations.

Main Results:

• Growth factors are implicated in key diabetic vascular complications.
• Established drug classes like ACE inhibitors and lipid-lowering drugs are used.
• Emerging therapies such as antisense oligonucleotides are under investigation.

Conclusions:

• Growth factor dysregulation is central to diabetic vascular complications.
• Pharmacological interventions targeting growth factors are crucial for managing diabetic disease.
• Novel approaches like antisense oligonucleotide delivery offer future therapeutic potential for diabetic macrovascular disease.